Impact of the metabolic syndrome on long-term outcomes in simultaneous kidney-pancreas transplantation

Transplantation Proceedings

Volumn 37, Issue 8, 2005, Pages 3549-3551

  Rogers, J ^a   Stratta, R J ^b,e   Lo, A ^c   Alloway, R R ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e WAKE FOREST BAPTIST HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DACLIZUMAB; HEMOGLOBIN A1C; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS;

ADULT; BODY MASS; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DATA ANALYSIS; DEMOGRAPHY; DIET; DRUG BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH EDUCATION; HUMAN; KIDNEY DISEASE; KIDNEY DYSFUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; TREATMENT OUTCOME; WAIST CIRCUMFERENCE;

ADULT; ANTIBODIES, MONOCLONAL; DIABETES MELLITUS, TYPE 1; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; METABOLIC SYNDROME X; PANCREAS TRANSPLANTATION; RISK FACTORS; TIME FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 27844572904     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.09.021     Document Type: Conference Paper

References (9)

1. S. Hariharan, C.P. Johnson, B.A. Breshnahan Improved graft survival after renal transplantation in the United States1988 to 1996 N Engl J Med 342 2000 605
2. B.L. Kasiske, K.L. Heim-Duthoy, K.L. Tortorice The variable nature of chronic declines in renal allograft function Transplantation 51 1991 330
3. M.R. Wiederkehr, J.Z. Ma, B.L. Kasiske Chronic renal allograft rejection immunologic and non immunologic risk factors Kidney Int 49 1996 518
4. L.C. Paul Chronic allograft nephropathy an update Kidney Int 56 1996 783
5. G.M. Chertow, E.L. Milford, H.S. Mackenzie Antigen independent determinants of cadaveric kidney transplant failure JAMA 276 1996 1732
6. S. Prommool, G.S. Jhangri, S.M. Cockfield Time dependency of factors affecting renal allograft survival J Am Soc Nephrol 11 2000 565
7. A.P.J. deVries, S.J.L. Bakker, W.J. van Son Metabolic syndrome is associated with impaired long-term renal allograft functionnot all component criteria contribute equally Am J Transplant 4 2004 1675
8. J. Chen, P. Muntner, L.L. Hamm The metabolic syndrome and chronic kidney disease in U.S. adults Ann Intern Med 140 2004 167
9. J.I. Cleeman Executive summary of the third report of the National Cholesterol Education ProgramNCEPexpert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 285 2001 2486